Impruvon Health Secures Funding to Revolutionize Medication Management! | July 11, 2023 | Source: UNIVERSITY SYSTEM of MARYLAND

Baltimore-based digital health startup, Impruvon Health is thrilled to announce the successful closure of a financing round aimed at meeting the skyrocketing demand for its groundbreaking enterprise medication management platform. Led by The Propel Baltimore Fund from TCP Venture Capital, this funding round proudly includes investments from the University System of Maryland (USM) Momentum Fund and New Dominion Angels.

Imagine a world where medication errors and wasted nursing time are a thing of the past! Impruvon Health, driven by its mission to optimize medication workflows, is now armed with the necessary capital to scale its operations nationwide and transform the lives of healthcare employees and the people they care for. We extend our heartfelt gratitude to our incredible investors for supporting us on this exhilarating journey.

With over 100,000 medication errors occurring annually in the United States alone, the urgency for change is clear. Impruvon’s interactive platform offers a tailored solution, empowering healthcare agencies to regulate medication management and establish organization-wide standards. Through smart-assisted compliance, the platform ensures automated reminders and access control, granting only the right staff access to the right medications at the right time. Plus, Impruvon’s seamless integrations and partnerships mean that facilities can adopt the platform without changing their existing pharmacy, medication packaging, or Electronic Health Record (EHR) system.

Join us as we celebrate this milestone investment that propels Impruvon Health toward its vision of a future where medication errors are eliminated, workflows are streamlined, and healthcare teams can focus on providing exceptional care. Together, we’ll make a profound impact on the long-term care industry and improve the lives of countless individuals. Stay tuned for the incredible journey ahead!